US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist
  • 13.720
  • -0.070-0.51%
Trading Apr 28 15:40 ET
1.83BMarket Cap-6.66P/E (TTM)

About Centessa Pharmaceuticals Company

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Company Profile

SymbolCNTA
Company NameCentessa Pharmaceuticals
Listing DateMay 28, 2021
Issue Price20.00
Founded2020
CEODr. Saurabh Saha, M.D.,PhD
MarketNASDAQ
Employees77
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address1 Ashley Road,3rd Floor
CityAltrincham
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeWA14 2DT
Phone44-7391-789784

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Saurabh Saha, M.D.,PhD
  • Chief Executive Officer and Director
  • 2.71M
  • Tia Bush
  • Chief Quality Officer and Chief Technology Officer
  • --
  • Karen Anderson
  • Chief People Officer
  • --
  • Iqbal Hussain
  • General Counsel, Chief Compliance Officer and Company Secretary
  • --
  • Dr. David Chao, PhD
  • Chief Administrative Officer
  • 1.32M
  • John Crowley
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Gregory M. Weinhoff, M.B.A.,M.D.
  • Chief Business Officer
  • --
  • Dr. Francesco De Rubertis, PhD
  • Chairman of the Board
  • --
  • Carol Stuckley, M.B.A.
  • Independent Director
  • 262.69K
  • Dr. Samarth Kulkarni, PhD
  • Independent Director
  • 255.19K
  • Dr. Mathias Hukkelhoven, PhD
  • Independent Director
  • 247.69K
  • Dr. Mary Lynne Hedley,PhD
  • Independent Director
  • 255.19K
  • Dr. Brett Zbar, M.D.
  • Independent Director
  • 257.69K
  • Dr. Arjun Goyal, M.B.A.,M.D.,M.Phil
  • Independent Director
  • 260.19K

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.